Explore more publications!
Cincinnati Wellness Review
Got News to Share?

Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on October 27, 2025

Polaris Vein & Aesthetics Showcases Full-Service Vein Care from Diagnosis to Treatment
October 27, 2025

Polaris Vein & Aesthetics Showcases Full-Service Vein Care from Diagnosis to Treatment

Indeterminate EIN Presswire
New Medical Assistant Program Launches in Youngstown to Strengthen Local Healthcare Workforce
October 27, 2025

New Medical Assistant Program Launches in Youngstown to Strengthen Local Healthcare Workforce

Indeterminate EIN Presswire
Hands-On Healthcare Training Comes to Cuyahoga Falls: Akron Medical Assistant School Opening Fall 2025
October 27, 2025

Hands-On Healthcare Training Comes to Cuyahoga Falls: Akron Medical Assistant School Opening Fall 2025

Indeterminate EIN Presswire
Cincinnati Dental Assistant School Announces Fall 2025 Opening
October 27, 2025

Cincinnati Dental Assistant School Announces Fall 2025 Opening

Indeterminate EIN Presswire
Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)
October 27, 2025

Anteris Technologies Announces First Patients Treated in DurAVR® THV Global Pivotal Trial (the “PARADIGM Trial”)

Indeterminate GlobeNewswire
Aurora Spine Launches New Biologics Portfolio
October 27, 2025

Aurora Spine Launches New Biologics Portfolio

Indeterminate GlobeNewswire
Elixir Medical anuncia resultados clínicos recientes y significativos sobre el Bioadaptador DynamX® que demuestran una reducción de casi el 50 % en las tasas de acontecimiento coronarios en comparación con el tratamiento de referencia actua
October 27, 2025

Elixir Medical anuncia resultados clínicos recientes y significativos sobre el Bioadaptador DynamX® que demuestran una reducción de casi el 50 % en las tasas de acontecimiento coronarios en comparación con el tratamiento de referencia actua

Indeterminate GlobeNewswire
Elixir Medical annuncia risultati clinici “late-breaking” significativi per DynamX® Bioadaptor che dimostrano una riduzione vicina al 50% dei tassi di eventi coronarici rispetto all’ attuale standard di cura per l’angioplastica coronarica p
October 27, 2025

Elixir Medical annuncia risultati clinici “late-breaking” significativi per DynamX® Bioadaptor che dimostrano una riduzione vicina al 50% dei tassi di eventi coronarici rispetto all’ attuale standard di cura per l’angioplastica coronarica p

Indeterminate GlobeNewswire
Elixir Medical gibt klinische Late-Breaking-Ergebnisse für DynamX® Bioadaptor bekannt, die eine signifikante Reduzierung von koronaren Ereignisraten um nahezu 50 % gegenüber dem aktuellen PCI-Behandlungsstandard zeigen
October 27, 2025

Elixir Medical gibt klinische Late-Breaking-Ergebnisse für DynamX® Bioadaptor bekannt, die eine signifikante Reduzierung von koronaren Ereignisraten um nahezu 50 % gegenüber dem aktuellen PCI-Behandlungsstandard zeigen

Indeterminate GlobeNewswire
Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX® Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care
October 27, 2025

Elixir Medical Announces Significant Late Breaking Clinical Results for DynamX® Bioadaptor Demonstrating Nearly 50% Reduction in Coronary Event Rates vs. Current PCI Standard of Care

Indeterminate GlobeNewswire
Elixir Medical annonce de nouveaux résultats cliniques significatifs pour le DynamX® Bioadaptor, démontrant une réduction de près de 50 % des taux d’événements coronariens par rapport à la norme actuelle de soins ICP
October 27, 2025

Elixir Medical annonce de nouveaux résultats cliniques significatifs pour le DynamX® Bioadaptor, démontrant une réduction de près de 50 % des taux d’événements coronariens par rapport à la norme actuelle de soins ICP

Indeterminate GlobeNewswire
Elixir Medical ogłasza przełomowe wyniki badań klinicznych DynamX® Bioadaptor – wskazujące na niemal 50% redukcję częstości występowania nieporządanych incydentów wieńcowych w porównaniu do obecnego standardu leczenia PCI
October 27, 2025

Elixir Medical ogłasza przełomowe wyniki badań klinicznych DynamX® Bioadaptor – wskazujące na niemal 50% redukcję częstości występowania nieporządanych incydentów wieńcowych w porównaniu do obecnego standardu leczenia PCI

Indeterminate GlobeNewswire
Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences
October 27, 2025

Amwell® to report third quarter 2025 operating results; company leaders to attend upcoming investor conferences

Indeterminate GlobeNewswire
Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process
October 27, 2025

Neuphoria Therapeutics Adopts Limited-Duration Stockholder Rights Plan to Protect Integrity of Process

Indeterminate GlobeNewswire
Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025
October 27, 2025

Myriad Genetics to Release Third Quarter 2025 Financial Results on November 3, 2025

Indeterminate GlobeNewswire
BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant
October 27, 2025

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

Indeterminate GlobeNewswire
MEDIA ADVISORY: Patients join Day of Action at Ontario Legislature to demand action on complaints about private clinics’ charges
October 27, 2025

MEDIA ADVISORY: Patients join Day of Action at Ontario Legislature to demand action on complaints about private clinics’ charges

Indeterminate GlobeNewswire
Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
October 27, 2025

Roivant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

Indeterminate GlobeNewswire
Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025
October 27, 2025

Immunovant to Report Financial Results for the Second Quarter Ended September 30, 2025, and Provide Business Update on Monday, November 10, 2025

Indeterminate GlobeNewswire
Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025
October 27, 2025

Outset Medical to Report Third Quarter 2025 Financial Results on Monday, November 10, 2025

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions